Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Pediatric Vaccine Market Size Changed, over the years?

The dimensions of the pediatric vaccine market have swiftly developed over the recent years. It is projected to proliferate from $45.9 billion in 2024 to $51.56 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.3%. The expansion in the historical period is credited to the rising incidence of chronic illnesses, immunization strategies to eliminate endemic diseases, and increased monetary support for vaccine advancement.

How Much Will the Pediatric Vaccine Market Be Worth in 2029?

Significant expansion is predicted for the pediatric vaccine market over the coming years, with an expected increase to $85.3 billion by 2029, representing a compound annual growth rate (CAGR) of 13.4%. This projected growth within the forecast period is largely due to a rise in cases of invasive cervical cancer, the presence of a robust late-stage pipeline, and fresh drug approvals, coupled with an increasing prevalence of infectious diseases. Key trends to watch during this forecast period are the development of combination vaccines to satisfy market demands, an inclination towards investing more in R&D for creating effective vaccines, a concentration on the creation of live attenuated vaccines, the use of novel immune engineering and advanced delivery systems, and the incorporation of artificial intelligence (AI) in the vaccine development process to streamline operations and simplify production.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp

Which is the Largest Company in the Pediatric Vaccine Market?

Major companies operating in the pediatric vaccine market include Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., AstraZeneca, GlaxoSmithKline PLC, Sinovac Biotech Ltd, Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo, CSL Limited, BIO-MED, Sun Pharmaceutical Industries Ltd, Sinopharm, Walvax biotechnology, Fosun Pharma, BioNTech, MCM Vaccine Company, Seqirus, Roche, Johnson & Johnson, Novartis, Connaught LaboratoriesInc., Wyeth-Ayerst, Grifols, Ataulfo de Paiva Foundation, Bio-Manguinhos–Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium

What Are the Main Market Drivers in the Pediatric Vaccine Industry?

The escalation in the occurrence of chronic illnesses like tuberculosis, diphtheria, and pneumonia amongst children and adolescents under 15 years is expected to stimulate the pediatric vaccines market’s expansion. There is an escalating risk of serious complications from infectious diseases among children and adolescents with chronic conditions. In March 2022, the Australian Bureau of Statistics, an independent Australian statistical agency responsible for data collection and analysis and offering factual suggestions, reported that nearly half of the total population (46.6%, or 11.6 million) suffered from at least one chronic ailment. This growing prevalence of chronic conditions in children heightens the requirement for immunization against these diseases, thereby propelling the pediatric vaccine market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2824&type=smp

How Is the Pediatric Vaccine Market Segments Structured?

The pediatric vaccine market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies

3) By Application: Infectious Disease, Allergy, Cancer

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Polyvalent Vaccines

What Strategic Trends Are Transforming the Pediatric Vaccine Market?

The need for innovative vaccines is progressively increasing to deliver enhanced protection against difficult infectious conditions (for example, tuberculosis, HIV/AIDS) and non-transmittable chronic illnesses such as cancer and neurodegenerative diseases. Novel strategies for vaccine development encompass structural immunogenic design, gene-driven vaccine platforms, and efficient adjuvant recombinant antigen formulations. To satisfy the growing need for innovative vaccines, there is an ongoing pursuit by pediatric vaccine producers and developers to innovate vaccine design and production techniques. For instance, Pfizer Inc., a U.S. pharmaceutical manufacturing giant, declared in April 2023, the approval of REVNAR 20, a 20-valent Pneumococcal Conjugate Vaccine for infants and children, by the U.S. FDA.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Which Global Regions Offer the Highest Growth in the Pediatric Vaccine Market?

North America was the largest region in the pediatric vaccine market in 2024. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2824

This Report Delivers Insight On:

1. How big is the pediatric vaccine market, and how is it changing globally?

2. Who are the major companies in the pediatric vaccine market, and how are they performing?

3. What are the key opportunities and risks in the pediatric vaccine market right now?

4. Which products or customer segments are growing the most in the pediatric vaccine market?

5. What factors are helping or slowing down the growth of the pediatric vaccine market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model